The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

Freeze on communications and contracts blocks NIH from sharing research materials with collaborators and patenting ...

Agency says move will save money and reduce bias, but researchers are concerned about associated staff reductions ...

The Elon Musk-backed group is calling the shots even after President Trump’s edict that they let individual agencies take the ...

Widely respected, he served as NIH acting director for two years under President Joe Biden. At 10 a.m. on Jan. 24, Tabak ...

That was the same time the Washington Post ran the story “ NIH reels with fear, uncertainty about future of scientific ...

HHS Secretary Robert F. Kennedy Jr. is reportedly ordering his staff to comply with the email request from Elon Musk for federal workers to justify their jobs.

Although university researchers don’t believe the change itself poses a clear risk to the scientific review process, ongoing ...

In what appears to be the first official break in policy, NIH's acting director, Matthew Memoli, MD, MS, sent an email to all NIH staff on Sunday walking back this demand, at least temporarily.

Administration officials pressured the NIH to avoid clear advice from the agency’s own lawyers to restart grant funding now.

However, the position was instead assigned to Dr. Matthew Memoli, a former top researcher at the National Institute of Allergy and Infectious Diseases and a known critic of COVID vaccine mandates.

Maintain the pause on grants. And the NIH’s acting director, Matthew Memoli, who until January was a relatively low-ranking flu researcher at the agency, has instructed leadership to stick to ...